Pegylated liposomal doxorubicin for platinum-resistant or refractory Müllerian carcinoma (epithelial ovarian carcinoma, primary carcinoma of Fallopian tube and peritoneal carcinoma): A single-institutional experience

By                    

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 35-38

Spandidos Publications

Access to resources Recommend Favorite

Analysis of Patients with Epithelial Ovarian Cancer or Fallopian Tube Carcinoma Retreated with Cisplatin after the Development of a Carboplatin Allergy

By Dizon D.S.   Sabbatini P.J.   Aghajanian C.   Hensley M.L.   Spriggs D.R.  

Gynecologic Oncology, Vol. 84, Iss. 3, 2002-03 ,pp. : 378-382

Elsevier

Access to resources Recommend Favorite

Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube and primary peritoneal cancer: a change in surgical approach

By  

The Women's Oncology Review, Vol. 4, Iss. 4, 2004-12 ,pp. : 263-264

Informa Healthcare

Access to resources Recommend Favorite

Resection of recurrent ovarian or fallopian tube carcinoma involving the liver*

By Yoon S.S.   Jarnagin W.R.   Fong Y.   DeMatteo R.P.   Barakat R.R.   Blumgart L.H.   Chi D.S.  

Gynecologic Oncology, Vol. 91, Iss. 2, 2003-11 ,pp. : 383-388

Elsevier

Access to resources Recommend Favorite

Phase 2 trial of single agent docetaxel in platinum and paclitaxel-refractory ovarian cancer, fallopian tube cancer, and primary carcinoma of the peritoneum

By Markman M.   Zanotti K.   Webster K.   Peterson G.   Kulp B.   Belinson J.  

Gynecologic Oncology, Vol. 91, Iss. 3, 2003-12 ,pp. : 573-576

Elsevier

Access to resources Recommend Favorite